Clinical Heart Failure Scenarios: From Prevention to Overt Disease and Rehabilitation, an Issue of Heart Failure Clinics, Volume 17-2

preview-18
  • Clinical Heart Failure Scenarios: From Prevention to Overt Disease and Rehabilitation, an Issue of Heart Failure Clinics, Volume 17-2 Book Detail

  • Author : Francesco Antonini-Canterin
  • Release Date : 2021-04-28
  • Publisher : Elsevier
  • Genre : Medical
  • Pages : 240
  • ISBN 13 : 9780323795869
  • File Size : 44,44 MB

Clinical Heart Failure Scenarios: From Prevention to Overt Disease and Rehabilitation, an Issue of Heart Failure Clinics, Volume 17-2 by Francesco Antonini-Canterin PDF Summary

Book Description: This issue of Heart Failure Clinics, guest edited by Dr. Francesco Antonini-Canterin, is dedicated to Clinical Heart Failure Scenarios: from Prevention to Overt Disease and Rehabilitation. This issue is one of four selected each year by series consulting editor Dr. Eduardo Bossone. This issue aims to provide a comprehensive overview over the broad spectrum of clinical scenarios of heart failure, starting from prevention in asymptomatic phase to acute and chronic congestive heart failure to modern rehabilitation.

Disclaimer: www.yourbookbest.com does not own Clinical Heart Failure Scenarios: From Prevention to Overt Disease and Rehabilitation, an Issue of Heart Failure Clinics, Volume 17-2 books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Cardiac Valvular Medicine

Cardiac Valvular Medicine

File Size : 16,16 MB
Total View : 894 Views
DOWNLOAD

The book will be written by the experts in the disease including imaging, interventional cardiology and surgical valve expertise. The book has five main section

Molecular Biology of Valvular Heart Disease

Molecular Biology of Valvular Heart Disease

File Size : 96,96 MB
Total View : 6028 Views
DOWNLOAD

The cellular mechanisms of valvular heart disease have not been elucidated until the last decade. To date, there is no medical therapy that is FDA or CE mark ap